New options for testing and treating some of the most common sexually transmitted diseases are becoming available.

Gonorrhoea is a common sexually transmitted infection (STI) that affects millions of people worldwide. Many people who have ...

The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced ...

From Chlamydia to Gonorrhea, Read on to know the top 8 dangerous and highly contagious STDs in the world. Check out their ...

The GARDP Foundation and Debiopharm have entered a collaboration and license agreement to pursue the development of a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae.

Welcome to UNMISSABLE, the Daily Beast’s Obsessed’s guide to the one thing you need to watch today. Whether it’s the most ...

Debio1453 is a first-in-class antibiotic candidate that targets an enzyme that’s essential for the growth of Neisseria ...

Last year, the US authorities approved the first at-home test that can detect three common infections in women — gonorrhea, ...

According to the New York Post, Manteris writes that a Nevada Athletic Commission insider told him Tyson had been taking ...

This sexually transmitted infection is almost entirely preventable. Here's what experts say you really need to know to ...

Gut microbiome researcher Purna C. Kashyap, MBBS, shares the latest insights on the role of probiotics, disorders of the ...

Among the most famous demonstrations of genetic mutations driving infection outcome is severe combined immunodeficiency (SCID ...